Skip to main content
SpringerLink
Log in

Adjuvante Strahlentherapie versus frühzeitige Salvage-Strahlentherapie nach radikaler Prostatektomie

Adjuvant radiotherapy versus early salvage radiotherapy after radical prostatectomy

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Swanson GP, Goldman B, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED (2008) The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation in those patients: data from Southwest Oncology Group 8794. J Urol 180(6):2453–2458. https://doi.org/10.1016/j.juro.2008.08.037

    Article  PubMed  PubMed Central  Google Scholar 

  2. Thompson IA, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED (2009) Adjuvant radiotherapy for pathologic T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 181(3):956–962. https://doi.org/10.1016/j.juro.2008.11.032

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Maréchal JM, Scalliet P, Haustermans K, Piérart M (2005) Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366:572–578. https://doi.org/10.1016/S0140-6736(05)67101-2

    Article  PubMed  Google Scholar 

  4. Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 380:2018–2027. https://doi.org/10.1016/S0140-6736(12)61253-7

    Article  PubMed  Google Scholar 

  5. Wiegel T, Bartkowiak D, Bottke D, Bronner C, Steiner U, Siegmann A, Golz R, Störkel S, Wilich N, Semjonow A, Stöckle M, Rübe C, Rebmann U, Kälbe T, Feldmann HJ, Wirth M, Hofmann R, Engenhart-Cabilic R, Hinke A, Hinkelbein W, Miller K (2014) Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10 year follow-up of the ARO 96-02/AUO AP 09/95 trial. Eur Urol 66(2):243–250. https://doi.org/10.1016/j.eururo.2014.03.011

    Article  PubMed  Google Scholar 

  6. Hackman G, Taari K, Tammela TL, Matikainen M, Kouri M, Joensuu T, Luukkaala T, Salonen A, Isotalo T, Pétas A, Hendolin N, Boström PJ, Aaltomaa S, Lehtoranta K, Hellström P, Riikonen J, Korpela M, Minn H, Kellokumpu-Lehtinen PL, Pukkala E, Hemminki A (2019) Randomised trial of adjuvant radiotherapy following radical prostatectomy versus radical prostatectomy alone in prostate cancer patients with positive margins or extracapsular extension. Eur Urol 76(5):586–595. https://doi.org/10.1016/j.eururo.2019.07.001

    Article  PubMed  Google Scholar 

  7. Sargos P, Chabaud S, Latorzeff I, Magné N, Benyoucef A, Supiot S, Pasquier D, Abdiche MS, Gilliot O, Graff-Cailleaud P, Silva M, Bergerot P, Baumann P, Belkacemi Y, Azria D, Brihoum M, Soulié M, Richaud P (2020) Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial. Lancet Oncol 21(10):3141–3152. https://doi.org/10.1016/S1470-2045(20)30454-X

    Article  Google Scholar 

  8. Kneebone A, Fraser-Browne C, Duchesne GM, Fisher R, Frydenberg M, Herschtal A, Williams SG, Brown C, Delprado W, Haworth A, Joseph DJ, Martin JM, Matthews JHL, Millar JL, Sidhom M, Spry N, Tang CI, Turner S, Wiltshire KL, Woo HH, Davis ID, Lim TS, Pearse M (2020) Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. Lancet Oncol 21(10):1331–1340. https://doi.org/10.1016/S1470-2045(20)30456-3

    Article  CAS  PubMed  Google Scholar 

  9. Vale CL, Fisher D, Kneebone A, Parker C, Pearse M, Richaud P, Sargos P, Sydes MR, Brawley C, Brihoum M, Brown C, Chabaud S, Cook A, Forcat S, Fraser-Brown C, Latorzeff I, Parmar MK, Tierney JF (2020) Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. Lancet 396:1422–1431. https://doi.org/10.1016/S0140-6736(20)31952-8

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radioonkologie/Strahlentherapie, Klinikum Fulda gAG, Campus Fulda, Universitätsmedizin Marburg, Pacelliallee 4, 36043, Fulda, Deutschland

    J. Lenzen & H. J. Feldmann

Authors
  1. J. Lenzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. J. Feldmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Lenzen.

Ethics declarations

Interessenkonflikt

J. Lenzen und H.J. Feldmann geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lenzen, J., Feldmann, H.J. Adjuvante Strahlentherapie versus frühzeitige Salvage-Strahlentherapie nach radikaler Prostatektomie. Onkologe 27, 610–612 (2021). https://doi.org/10.1007/s00761-021-00942-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-021-00942-7

Search

Navigation